Anatomoradiological correiation of breast alterations by means of core biopsy and fíne-needle aspiration cytology
Keywords:
Core biopsy, Needie biopsy, Breast abnormalitiesAbstract
In the period between March 8'\ 1994 and April 13th, 2000, one hundred and fifteen breast
imaging examinations (mammography, sonography or both) were performed and further pathological investigation were indicated at MamoRad - Centro de Diagnóstico por Imagem de Porto
Alegre-RS - using 44 core biopsies and 71 fine-needle aspiration cytology (FNAC) under stereotactic
guidance or ultrassonografic control. 75 lesions were considered suspicious (category 4) and 40
were considered highly suspicious (category 5), according to The American College of Radiology
(ACR) Breast Imaging Reporting and Data System (Bi-Rads) assortment. The histopathological
results of the 44 core biopsies were malignant in 12 cases and benign in 30 cases; two cases
were considered inconclusive and there were request for excisional technique. The results of the
71 FNAC were 21 cases benign and 23 malignant; 27 cases unconclusive and there were request
for histologycal confirmation. A comparison of breast imaging exams rank to pathology results
allowed to obtain values of sensitivity (100%), predictive positive value of malignancy (27.94%
and 74.35%) and accuracy (27.94% and 74.35%) offourand five Bi-Rads categories. Indeed, it
was estimated sensitivity (85.71% and 100%), specificity (100% and 70%), predictive positive
values of malignancy (100% and 78.57%) and accuracy (95.45% and 84.1%) of core biopsies
and FNACs comparing to surgical results, allowing the analysis the designation's accomplishment
ofeach kind of biopsy procedure. The data acquired are according to Medicai Literature.
Downloads
References
1.AZAVEDO E, AUE G, SVANE G.
Stereotactic Fine-needle Biopsy in 2.594 mammographically detected non-palpable
lesions. Lancet 1989; 8646: 1033-6.
2.AZEVEDO CM. Radiologia da mama. Rio
de Janeiro: Guanabara-Koogan. 1994;
105-76, 179-82, 187-98.
3.BASEGIO D. Câncer de mama:
abordagem multidisciplinar. Ia ed. Rio
de Janeiro: Revinter. 1999; 60-63.
4.BASSETT LW, KLIME-SMITH C,
SUTHERLAND LK et al. Automated and
hand-held breast US: effect on patient management. Radiology 1987; 165:
103-8.
5.BASSETT LW, LIU TH, GIULIANO
AE, GOLD RH. The prevalence of
carcinoma in palpable vs impalpable
mammographically detected lesions. AJR 1991; 157: 21-4.
6.BAKER LH. Breast câncer detection
demonstration project: five-year
summary report. CA Câncer J Clin Revinter 1982, 32: 194-225.
7. BIRD RE. Professional quality assurance
for mammographic screening programs. Radiology 1990; 177: 587. * 8. CANELLA EO, MARCHIORI E, OLIVEIRA
C, LUNA M, ALMEIDA L, TRAVASSOS M. Correlação anatomorradiológica
nas lesões mamárias através de core
biópsia. Radiol Bras 1999; 32: 55-61.
9.D'ORSI CJ. The American College of Radiology breast imaging reporting
and data system 2"d ed. Reston (VA): American College of Radiology. 1995.
10.DOYLE AJ, MURRAY KA, NELSON EW, BRAGG DG. Selective use of imageguided large-core needle biopsy of the
breast: accuracy and cost-effectiveness. AJR 1995, 165: 281-4.
11.DOWLATSHAHI K, GENT HJ, SCHMIDT R, JOKICH PM, BIBBO M, SPRENGER E. Nonpalpable breast tumors: diagnosis
with stereotaxic localization and fineneedle aspiration. Radiology 1989; 170:
427-33.
12.DOWLATSHAHI K, JOKICH PM, SCHMIDT R, BIBBO M, DAWSON PJ. Cytologic
diagnosis of occult breast lesions using
stereotaxic needle aspiration. Arch Surg
1987, 122: 1343-6.
13.DOWLATSHAHI K, YAREMKO ML, KLUSKENS LF, JOKICH PM. Nonpalpable
breast Lesions: findings of stereotaxic
needle-core biopsy and fine-needle
aspiration cytology. Radiology 1991;
181: 745-50.
14.FARACO BE, MOURA FM. Língua e literatura. 7a ed. São Paulo: Ática. 1987.
15.FERREIRA ABH. Minidicionário da língua
portuguesa. 2a ed. Rio de Janeiro: Nova
Fronteira. 1988.
16.FLETCHERL RH, FLETCHER SW, WAGNER
EH. Epidemiologia clínica. 2a ed. Porto Alegre: Artes Médicas. 1991.17.FRASSON A, KOCH H, MORIGUCHI EH
et al. Lesões mamárias não-palpáveis:
quando não biopsiar? Rev Bras Mastol
1999; 9: 7-14.
18.GISVOLD JJ, GOELINER JR, GRANT CS. Breast biopsy: a comparative study
of stereotaxically guided core and
excisional techniques. AJR 1994; 162:
815-20.
19.GISVOLD JJ, MARTIN JK. Prebiopsy
localization of nonpalpable breast
lesions. AJR 1984; 143:477.
20.GORDON PB, GOLDENBERG SL. Malignant breast masses detected only
by ultrasound: a retrospective review.
Câncer 1995; 76: 626-30.
21.HALL FM, FRANK HA. Preoperative
localization of nonpalpable breast
lesions. AJR 1979; 132: 101-5.
22.HALL FM, STORELLA JM, SILVERSTONE DZ, WYSHAK G. Nonpalpable breast
lesions: recommendations for biopsy
based on suspicion of carcinoma at mammography. Radiology 1988; 167:
353-8.
23.HARTER LP, CURTIS JS, PONTO G, CRAIG
PH. Malignant seeding of the needle
track during stereotaxic core needle
breast biopsy. Radiology 1992; 185:
713-4.
24.HERMANN G, JANUS C, SCHWARTZ IS, KRIVISKY B, BIER S, RABINOWITZ JG. Nonplapable breast lesions: accuracy
of prebiopsy mammographic diagnosis.
Radiology 1987; 165: 323-6.
25.KOPANS DB. Imagem da mama. 2a ed. Rio de Janeiro: Medsi. 2000; 211-28,
375-411, 439-43, 637-51, 761-96.
26.KOPANS DB. Review of stereotaxic
large-core needle biopsy and surgical
biopsy results in nonpalpable breast
lesions. Radiology 1993; 189: 665-6.
27.LANDERCASPER J, GUNDERSEN Jr. SB, GUNDERSEN AL, COGBILLTH, TRAVELLI R, STRUTT P. Needle localization and
biopsy of nonpalpable lesions of the
breast. SGO 1987; 164: 399-403.
28.LIBERMAN L, DERSHAW DD, DEUCH BM
et al. Screening mammography: value
in women 35-39 years old. AJR 1993;
161: 53-6.
29.LINDFORS KK, ROSENQUIST CJ. Needle
core biopsy guided with mammography:
a study of cost-effectiveness. Radiology
1994; 190: 217-2.
30.LUFT CP. Novo guia ortográfico. 6a ed.
Porto Alegre: Globo. 1977.
31.MARANHAO N, COSTA IMG, LIMA MCCA. A biópsia estereotáxica no diagnóstico
das microcalcificações mamárias. Radiol Bras 1997; 30: 125-31.
32.MEYER JE, KOPANS DB. Analysis of mammographically obvious carcinomas
of the breast with benign results upon
initial biopsy. SGO 1981; 153: 570-2.
33.MEYER JE, KOPANS DB. Preoperative
roentgenographically guided
percutaneous localization of occult
breast lesions. Three-year experience with 180 patients and description of a method. Arch Surg 1982; 117: 65-8.
34.MEYER JE, KOPANS DB, STOMPER
PC, LINDFORDS KK. Occult breast
abnormalities: percutaneous
preoperative needle localization.
Radiology 1984; 150: 335-7.
35.MOSKOWITZ M. Breast câncer: agespecific growth rates and screening
strategies. Radiology 1986; 161: 37-
41.
36.PARKER SH, BURBANK F, JACKMAN RJ
et al. Percutaneous large-core breast
biopsy: a multi-institutional study.
Radiology 1994; 193: 359-64.
37.PARKER SH, LOVIN JD, JOBE WE, BURKE BJ, HOPPER KD, YAKES WF. Nonpalpable
breast lesions: stereotactic automated
large-core biopsies. Radiology 1991;
180: 403-7.
38.PROCTER P. Cambrigde international
dictionary of english. 2nd ed. Cambridge:
Cambridge University Press. 1996.
39.ROSEN PP, GROSHEN S, SAIGO PE
et al. A long-term follow-up study of
survival in stage I (T1N0M0) and stage
II (T1N1M0) breast carcinoma. J Clin Oncol 1989; 7: 355-66.
40.ROSENBERG AL, SCHWARTZ GE,
FEIG SA, PATCHERFSY AS. Clinically
occult breast lesions: localization
and significance. Radiology 1987;
162:167.
41.RUMACK CM, WILSON SR, CHARBONEAU
JW. Tratado de ultra-sonografia
diagnostica. 2a ed. Rio de Janeiro: Guanabara-Koogan. 1998; 638,
642-70.
42.SMART CR. Highlights of the evidence
of benefit for woman aged 40-49 years
front the follow-up of the Breast Câncer Detection Demonstration Project. Câncer
1994; 74: 296-300.
43.SULLIVAN DC. Needle core biopsy of mammographic lesions. AJR 1994;
162: 601-8.
44.SUTTON D, WHITEHOUSE RW, JENKINS
JPR, DAVIES ER. Texbook of radiology
and imaging. 6th ed. London: Churchill
Livingstone. 1998; 1430-58.
45.TABAR L, DUFF SW, KRUSEMO UB. Detection method, tumor size and node metastases in breast cancers diagnosed
during a trial of breast câncer screening.
Eur J Câncer Clin Oncol 1987; 23:
959-62.
46.TABAR L, FAGERBERG G, DAY N
et al. Breast câncer treatment and
natural history: new insigts from
results of screening. Lancet 1992;
339: 412-4.
47.TABAR L, FAGERBERG G, DAY NE, HOLMBERG L. What is the optimum
interval between mammographic
screening examinations? An analysis
based on the latest results of the
swedish two county breast screening
trial. Br J Câncer 1989; 55: 547-51.
48.TABAR L, FAGERBERG G, DUFFY S et
al. Update of the swedish two county
program of mammographic screening
for breast câncer. Radiol Clin North Am
1992; 30: 187-210.
49.THURFJELL EL, LERNEVALL KA,
TAUBER AAS. Benefit of independent
double reading in population-based
mammography screening program. Radiology 1994; 191: 241-4.
50.TINNEMANS JGM, WOBES T, HOLLAND R et al. Mammographic
and histopathologic correlation of
nonpalpable lesions of the breast
and the reliability of frozen section
diagnosis. SGO; 165: 523-9.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Andréa Düren Centeno, Radia dos Santos Koch, Letícia Freurd, Hilton Augusto Koch
This work is licensed under a Creative Commons Attribution 4.0 International License.
